NGLFINE

NGL Fine - Chem Share Price

 

 

Start SIP in NGLFINE

Start SIP

Performance

  • Low
  • ₹1,317
  • High
  • ₹1,342
  • 52 Week Low
  • ₹957
  • 52 Week High
  • ₹2,050
  • Open Price₹1,317
  • Previous Close₹1,310
  • Volume385

Investment Returns

  • Over 1 Month -0.82%
  • Over 3 Month -8.12%
  • Over 6 Month + 34.37%
  • Over 1 Year -32.49%

Smart Investing Starts Here Start SIP with NGL Fine - Chem for Steady Growth!

Invest Now

NGL Fine - Chem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.9
  • PEG Ratio
  • -0.8
  • Market Cap Cr
  • 826
  • P/B Ratio
  • Average True Range
  • 43.94
  • EPS
  • 33.47
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -26.84
  • RSI
  • 49.42
  • MFI
  • 76.71

NGL Fine - Chem Financials

NGL Fine - Chem Technicals

EMA & SMA

Current Price
₹1,337.00
+ 27 (2.06%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹1,327.83
  • 50 Day
  • ₹1,365.90
  • 100 Day
  • ₹1,370.92
  • 200 Day
  • ₹1,407.02

Resistance and Support

1331.83 Pivot Speed
  • R3 1,371.17
  • R2 1,356.33
  • R1 1,346.67
  • S1 1,322.17
  • S2 1,307.33
  • S3 1,297.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

NGL Fine-Chem Ltd. manufactures pharmaceutical intermediates and active pharmaceutical ingredients (APIs), primarily serving the veterinary, pharmaceutical, and cosmetic industries. It supplies high-quality products to domestic and international markets, focusing on reliability and innovation in chemical synthesis.

Ngl Fine-Chem has an operating revenue of Rs. 408.51 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 8% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at C which is evident from recent supply seen, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

NGL Fine - Chem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-08-01 Quarterly Results
2025-05-22 Audited Results & Final Dividend
2025-02-07 Quarterly Results
2024-11-08 Quarterly Results
Date Purpose Remarks
2025-08-12 FINAL Rs.1.75 per share(35%)Final Dividend
2024-08-16 FINAL Rs.1.75 per share(35%)Final Dividend
2023-08-18 FINAL Rs.1.75 per share(35%)Final Dividend
2022-06-23 FINAL Rs.1.75 per share(35%)Final Dividend
View NGL Fine - Chem Dividend History Arrow

NGL Fine - Chem F&O

NGL Fine - Chem Shareholding Pattern

72.74%
0%
0%
23.01%
4.25%

About NGL Fine - Chem

  • NSE Symbol
  • NGLFINE
  • BSE Symbol
  • 524774
  • Managing Director
  • Mr. Rahul Nachane
  • ISIN
  • INE887E01022

Similar Stocks to NGL Fine - Chem

NGL Fine - Chem FAQs

NGL Fine - Chem share price is ₹1,337 As on 25 December, 2025 | 04:37

The Market Cap of NGL Fine - Chem is ₹826 Cr As on 25 December, 2025 | 04:37

The P/E ratio of NGL Fine - Chem is 39.9 As on 25 December, 2025 | 04:37

The PB ratio of NGL Fine - Chem is 2.8 As on 25 December, 2025 | 04:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23